EX-99.2 3 a20211231ex-992q4prerelease.htm EX-99.2

Exhibit 99.2

Intuitive Surgical, Inc.

Unaudited Preliminary Quarterly and Annual Revenue Data and Metrics

						Three Months Ended																		Twelve Months Ended
						December 31, 2021						December 31, 2020						Change						December 31, 2021						December 31, 2020						Change
Revenue ($Millions)
Instruments and Accessories						$	842.8					$	746.9					13		%				$	3,100.5					$	2,455.7					26		%
Systems						469.9						366.8						28		%				1,693.4						1,178.9						44		%
Services						238.0						215.4						10		%				916.2						723.8						27		%
Total Revenue						$	1,550.7					$	1,329.1					17		%				$	5,710.1					$	4,358.4					31		%
% Recurring Revenue (1)						75		%				76		%										75		%				77		%
Da Vinci Surgical System Shipments by Geography
United States						235						196						20		%				865						600						44		%
Europe						63						54						17		%				232						136						71		%
Asia						71						48						48		%				203						157						29		%
Other Markets						16						28						(43)		%				47						43						9		%
Total Systems*						385						326						18		%				1,347						936						44		%
Unit Shipments Involving Trade-Ins						117						161						(27)		%				510						447						14		%
Ion System Shipments						31						4						675		%				93						26						258		%
Da Vinci Surgical System Shipments by Model
Single Console X Systems						48						45						7		%				160						124						29		%
Dual Console X Systems						1						1						—		%				11						8						38		%
Single Console Xi Systems						255						203						26		%				824						592						39		%
Dual Console Xi Systems						71						65						9		%				322						186						73		%
SP Systems						10						12						(17)		%				30						26						15		%
Total Systems*						385						326						18		%				1,347						936						44		%
* Da Vinci Surgical Systems Shipped under Operating Leases						143						120						19		%				517						317						63		%
Other da Vinci Surgical System Metrics
Procedures (Thousands)						431						361						19		%				1,594						1,243						28		%
Average Selling Price ($Millions)						$	1.45					$	1.43					1		%				$	1.55					$	1.50					3		%
Inst & Accy Revenue/Procedure ($Thousands)						$	1.94					$	2.06					(6)		%				$	1.93					$	1.97					(2)		%
Installed Base (2)						6,730						5,989						12		%				6,730						5,989						12		%

(1) We present operating lease revenue, which is classified as systems revenue, as a component of total recurring revenue.

(2) During the fourth quarters of 2021 and 2020, we performed a verification audit of our installed base records that identified 54 and 33 systems, respectively, mostly older standard and S models, which had been retired. We removed these systems from our installed base estimate during the fourth quarters of 2021 and 2020, respectively.

Page 1 of 2

---

Intuitive Surgical, Inc.

Unaudited Preliminary Trended Annual Procedure Data

						Approximate Procedures (Thousands)																		Percentage Change*
						2021						2020						2019						2021						2020
United States
General Surgery						589						434						421						36		%				3		%
Gynecology						316						267						282						19		%				(6)		%
Urology						153						134						138						14		%				(3)		%
Other						51						41						42						26		%				(3)		%
Total United States						1,109						876						883						27		%				(1)		%
Total Outside of the United States						485						367						346						32		%				6		%
Total Worldwide						1,594						1,243						1,229						28		%				1		%
* The approximate procedures are rounded to thousands, but the percentage changes are based on unrounded approximate procedures.

This report contains forward-looking statements. Such statements relate to unaudited preliminary trended annual procedure data, unaudited preliminary fourth quarter and full year 2021 revenue data and metrics, and other related subjects. The unaudited preliminary results are subject to the completion of Intuitive’s final closing procedures and an audit by the Company’s independent registered accounting firm and, therefore, are subject to adjustment. These forward-looking statements are based on Intuitive’s current plans and expectations and are subject to risks and uncertainties that could cause actual events and results to vary significantly from those implied by such statements. These forward-looking statements should, therefore, be considered in light of various important factors, including, but not limited to, the following: completion of the Company’s final closing procedures, final adjustments, and other developments that may arise in the course of audit and review procedures; and other risk factors under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, and the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2021, as updated by the Company’s other filings with the Securities and Exchange Commission.

Page 2 of 2